Mutation-specific control of BCR-ABL T315I positive leukemia with a recombinant yeast-based therapeutic vaccine in a murine model.
Bui MR, Hodson V, King T, Leopold D, Dai S, Fiolkoski V, Oakes S, Duke R, Apelian D, Franzusoff A, DeGregori J. Mutation-specific control of BCR-ABL T315I positive leukemia with a recombinant yeast-based therapeutic vaccine in a murine model. Vaccine. 2010 Aug 23; 28(37):6028-35.
-
Amino Acid Sequence
-
Animals
-
Cancer Vaccines
-
Disease-Free Survival
-
Fusion Proteins, bcr-abl
-
Genes, MHC Class I
-
Immunotherapy
-
Leukemia, Experimental
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
-
Mice
-
Mice, Inbred BALB C
-
Mice, Inbred C57BL
-
Models, Molecular
-
Molecular Sequence Data
-
Protein Structure, Tertiary
-
Saccharomyces cerevisiae
-
Vaccines, Synthetic